Developer docs
API playgroundTry for free, no card

Search company profiles

Clinical Trial Service

Full company profile

uuid000cv3r

Namestring
Clinical Trial Service
Legal namestring
EmVenio
Company typeenum
Private
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLosser, Netherlands
HQ citystring
Losser
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
decentralized clinical trials, clinical research services, contract research organization, mobile clinical visits, patient recruitment
Industry3 codes
1Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
CodeHLAGACAHPrimaryYes
2Clinical Trial Site Operations & Study Coordination
CodeHLAGACAEPrimaryNo
3Clinical Trial Monitoring Support (On-site/Remote)
CodeHLAGACAGPrimaryNo
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

EmVenio Clinical Research (formerly Clinical Trial Service) generates revenue by providing decentralized clinical trial services to pharmaceutical sponsors and contract research organizations (CROs). Services include mobile research visits, site network operations, and patient navigation support. Revenue is derived from service contracts for clinical study delivery.

prnewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Patient Navigator
Description

A solution designed to reduce logistical and financial barriers to clinical trial participation by providing personalized support including transportation and daily logistics.

prnewswire.com
Core offering1 text field

Clinical Trial Service (now operating under the EmVenio Clinical Research brand) is a contract research organization that delivers decentralized clinical trial services to pharmaceutical sponsors and other CROs. Its offering combines Mobile Research Visits conducted at patient locations, a global Site Network of Research Centers and Community Research Sites, and Patient Navigator™ personalized patient support, enabling sponsors to accelerate enrollment, improve retention and reach underrepresented populations across more than 90 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 800+ clinical studies delivered across 90+ countries with industry-leading retention rates
+2 more records
Product overview1 text field

EmVenio Clinical Research (formerly Clinical Trial Service) operates as a unified platform offering three integrated solutions: Mobile Visits (deploying clinicians to patient locations), Site Network (community-based research centers), and Patient Navigator™ (personalized patient support services). The platform is powered by the ARC(H) framework — Access, Reach, Community, and Human-Centered Research — which guides all service delivery across 90+ countries. The company focuses on decentralized clinical trials, enabling sponsors and CROs to reach more patients while improving enrollment speed and retention through mobile, virtual, and community-based research options.

Product and service3 records
1Mobile Visits
CategoryDecentralized clinical trial services
Description

Decentralized clinical trial solution in which Mobile Research Clinicians travel to patients' homes, workplaces or other convenient locations to conduct research visits, bringing clinical trials directly to participants. Sold to pharmaceutical sponsors and CROs as part of the consolidated EmVenio Clinical Research offering.

2Site Network
CategoryDecentralized clinical trial services
Description

Network of Research Centers and Community Research Sites that brings clinical trials to previously untapped communities, expanding access and participation through distributed research facilities across 90+ countries. Sold to pharmaceutical sponsors and CROs as part of the EmVenio Clinical Research offering.

3Patient Navigator™
CategoryPatient support services
Description

Patient support solution providing personalized assistance from transportation to daily logistics, helping patients overcome barriers to clinical trial participation and improving retention rates. Used by pharmaceutical sponsors and CROs as part of decentralized trial delivery.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Professional Case Management is the parent company of EmVenio Clinical Research. PCM Trials, EmVenio Research, and Clinical Trial Service were acquired by PCM Trials in 2024 and consolidated under a unified EmVenio Clinical Research brand. Professional Case Management provides the overarching corporate structure and resources supporting the global decentralized clinical trial operations.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the world's largest CRO offering decentralized clinical trial capabilities through its IQVIA Decentralized Trials platform. Comparable as a full-service CRO that competes with EmVenio for DCT engagements, though operating at much larger scale and with broader service breadth.

TypeBroad incumbent
Description

ICON is a global CRO with deep DCT capabilities following its PRA Health Sciences acquisition. Directly comparable as a sponsor-facing CRO competing for decentralized trial engagements, with comparable global reach and enterprise sponsor relationships.

TypeBroad incumbent
Description

Labcorp is a major CRO and diagnostic services provider offering decentralized trial solutions. Comparable as a full-service clinical research provider to pharmaceutical sponsors with overlapping DCT offerings.

TypeDirect peer
Description

Science 37 is a pure-play decentralized clinical trial platform focused on mobile nurse visits and virtual trial delivery. Most directly comparable to EmVenio on operating model—mobile clinicians, virtual visits, and decentralized site services for pharma sponsors.

TypeBroad incumbent
Description

Medpace is a mid-to-large CRO providing full-service clinical development to pharma and biotech sponsors. Comparable as a sponsor-facing CRO competing for global trial engagements, though with less DCT specialization than EmVenio.

TypeBroad incumbent
Description

Syneos Health is a global CRO with patient-centric decentralized trial offerings and patient recruitment expertise. Comparable as a full-service CRO serving pharma sponsors with overlapping DCT and patient engagement capabilities.

TypeEmerging player
Description

THREAD is a DCT technology platform enabling decentralized and hybrid clinical trials. Comparable as a decentralized trial enabler for sponsors, but operating as a technology platform rather than a services-led operator like EmVenio.

TypeEmerging player
Description

Medable is a DCT technology platform providing eCOA, eConsent, telehealth, and remote monitoring tools for decentralized trials. Comparable as a decentralized trial infrastructure provider serving overlapping sponsor customers, though technology-led rather than services-led.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-size CRO providing full-service clinical development to pharma and biotech sponsors. Comparable to EmVenio as a similarly-sized CRO competing for global trial engagements with sponsor-facing service delivery.

TypeEmerging player
Description

Clario is a clinical trial technology and eCOA provider supporting decentralized trials with endpoint and data capture solutions. Comparable as a DCT infrastructure provider for pharma sponsors, though more technology-focused than EmVenio's services-led model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinical Trial Service

Clinical Research Servicesclinicaltrialservice.com

Clinical Trial Service firmographics

Firmographics
Name
Clinical Trial Service
Legal name
EmVenio
Website
https://clinicaltrialservice.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Clinical Trial Service industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
akta.pro secondary industries
Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

  • Decentralized clinical trials
  • Clinical research services
  • Contract research organization
  • Mobile clinical visits
  • Patient recruitment

Where Clinical Trial Service is headquartered

Location

Headquarters

HQ city
Losser
HQ country
Netherlands
HQ region
Europe

Markets served

Clinical Trial Service business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Research Services: EmVenio Clinical Research (formerly Clinical Trial Service) generates revenue by providing decentralized clinical trial services to pharmaceutical sponsors and contract research organizations (CROs). Services include mobile research visits, site network operations, and patient navigation support. Revenue is derived from service contracts for clinical study delivery.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Clinical Trial Service product offering

Product offering

Core offering

Clinical Trial Service (now operating under the EmVenio Clinical Research brand) is a contract research organization that delivers decentralized clinical trial services to pharmaceutical sponsors and other CROs. Its offering combines Mobile Research Visits conducted at patient locations, a global Site Network of Research Centers and Community Research Sites, and Patient Navigator™ personalized patient support, enabling sponsors to accelerate enrollment, improve retention and reach underrepresented populations across more than 90 countries.

Product overview

EmVenio Clinical Research (formerly Clinical Trial Service) operates as a unified platform offering three integrated solutions: Mobile Visits (deploying clinicians to patient locations), Site Network (community-based research centers), and Patient Navigator™ (personalized patient support services). The platform is powered by the ARC(H) framework — Access, Reach, Community, and Human-Centered Research — which guides all service delivery across 90+ countries. The company focuses on decentralized clinical trials, enabling sponsors and CROs to reach more patients while improving enrollment speed and retention through mobile, virtual, and community-based research options.

Differentiator

Problem solved

Functional benefit

Brands

  • Patient Navigator: A solution designed to reduce logistical and financial barriers to clinical trial participation by providing personalized support including transportation and daily logistics.

Products and services

  • Mobile Visits Decentralized clinical trial solution in which Mobile Research Clinicians travel to patients' homes, workplaces or other convenient locations to conduct research visits, bringing clinical trials directly to participants. Sold to pharmaceutical sponsors and CROs as part of the consolidated EmVenio Clinical Research offering.
  • Site Network Network of Research Centers and Community Research Sites that brings clinical trials to previously untapped communities, expanding access and participation through distributed research facilities across 90+ countries. Sold to pharmaceutical sponsors and CROs as part of the EmVenio Clinical Research offering.
  • Patient Navigator™ Patient support solution providing personalized assistance from transportation to daily logistics, helping patients overcome barriers to clinical trial participation and improving retention rates. Used by pharmaceutical sponsors and CROs as part of decentralized trial delivery.

Quantifiable outcome

  • 800+ clinical studies delivered across 90+ countries with industry-leading retention rates
  • +2 more outcomes

Companies that use Clinical Trial Service

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Clinical Trial Service technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Clinical Trial Service partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Professional Case Management (Parent)coreStrategic or Co-development Partner · 1 January 2024Professional Case Management is the parent company of EmVenio Clinical Research. PCM Trials, EmVenio Research, and Clinical Trial Service were acquired by PCM Trials in 2024 and consolidated under a unified EmVenio Clinical Research brand. Professional Case Management provides the overarching corporate structure and resources supporting the global decentralized clinical trial operations.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Clinical Trial Service competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the world's largest CRO offering decentralized clinical trial capabilities through its IQVIA Decentralized Trials platform. Comparable as a full-service CRO that competes with EmVenio for DCT engagements, though operating at much larger scale and with broader service breadth.
  • ICON plc: ICON is a global CRO with deep DCT capabilities following its PRA Health Sciences acquisition. Directly comparable as a sponsor-facing CRO competing for decentralized trial engagements, with comparable global reach and enterprise sponsor relationships.
  • Labcorp Drug Development: Labcorp is a major CRO and diagnostic services provider offering decentralized trial solutions. Comparable as a full-service clinical research provider to pharmaceutical sponsors with overlapping DCT offerings.
  • Medpace: Medpace is a mid-to-large CRO providing full-service clinical development to pharma and biotech sponsors. Comparable as a sponsor-facing CRO competing for global trial engagements, though with less DCT specialization than EmVenio.
  • Syneos Health: Syneos Health is a global CRO with patient-centric decentralized trial offerings and patient recruitment expertise. Comparable as a full-service CRO serving pharma sponsors with overlapping DCT and patient engagement capabilities.

Direct peers

  • Science 37: Science 37 is a pure-play decentralized clinical trial platform focused on mobile nurse visits and virtual trial delivery. Most directly comparable to EmVenio on operating model—mobile clinicians, virtual visits, and decentralized site services for pharma sponsors.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO providing full-service clinical development to pharma and biotech sponsors. Comparable to EmVenio as a similarly-sized CRO competing for global trial engagements with sponsor-facing service delivery.

Emerging players

  • THREAD Research: THREAD is a DCT technology platform enabling decentralized and hybrid clinical trials. Comparable as a decentralized trial enabler for sponsors, but operating as a technology platform rather than a services-led operator like EmVenio.
  • Medable: Medable is a DCT technology platform providing eCOA, eConsent, telehealth, and remote monitoring tools for decentralized trials. Comparable as a decentralized trial infrastructure provider serving overlapping sponsor customers, though technology-led rather than services-led.
  • Clario: Clario is a clinical trial technology and eCOA provider supporting decentralized trials with endpoint and data capture solutions. Comparable as a DCT infrastructure provider for pharma sponsors, though more technology-focused than EmVenio's services-led model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Clinical Trial Service social profiles

Digital presence

Clinical Trial Service financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinical Trial Service leadership team

Management profile

Number of profiles

Clinical Trial Service funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinical Trial Service M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Trial Service

What does Clinical Trial Service do?

Clinical Trial Service (now operating under the EmVenio Clinical Research brand) is a contract research organization that delivers decentralized clinical trial services to pharmaceutical sponsors and other CROs. Its offering combines Mobile Research Visits conducted at patient locations, a global Site Network of Research Centers and Community Research Sites, and Patient Navigator™ personalized patient support, enabling sponsors to accelerate enrollment, improve retention and reach underrepresented populations across more than 90 countries.

Is Clinical Trial Service a public or private company?

Clinical Trial Service is a private company. It is classified as corporate owned and is currently operating.

When was Clinical Trial Service founded?

Clinical Trial Service was founded in 2008. It employs 11 to 50 people.

Where is Clinical Trial Service based?

Clinical Trial Service is headquartered in Losser, Netherlands, in the Europe region.

How does Clinical Trial Service make money?

One revenue line is on record: clinical Research Services.

Who are Clinical Trial Service's main competitors?

Broad incumbents on record are IQVIA, ICON plc, Labcorp Drug Development, Medpace and Syneos Health. Direct peers are Science 37 and Worldwide Clinical Trials. Emerging players are THREAD Research, Medable and Clario.

Does Clinical Trial Service have an API?

No public API is recorded for Clinical Trial Service.

What industry is Clinical Trial Service in?

Clinical Trial Service's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePCM Trials, EmVenio Research y Clinical Trial Service cambian su nombre a EmVenio Clinical ResearchPCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, announced they are consolidating under a single brand name: EmVenio Clinical Research. The rebranding unifies the three companies—which offer complementary clinical trial services including mobile nurse visits, decentralized trials, and community research sites—into one entity operating across more than 80 countries with approximately 5,000 professionals. As part of the announcement, the company also launched Patient Navigator™, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation, particularly in rare disease and pediatric therapeutic areas.PR NewswirePCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical ResearchPCM Trials, EmVenio Research, and Clinical Trial Service have consolidated under the unified brand EmVenio Clinical Research to offer sponsors and contract research organizations greater flexibility and global reach, now operating in over 80 countries with approximately 5,000 professionals. The rebranded entity is also launching Patient Navigator™, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation and improve patient retention. PCM Trials had previously acquired Clinical Trial Service in 2024 and subsequently acquired EmVenio Research, forming the alliance now unified under the EmVenio name.PR NewswirePCM Trials, EmVenio Research et Clinical Trial Service changent de nom pour devenir EmVenio Clinical ResearchPCM Trials and its subsidiaries EmVenio Research and Clinical Trial Service have consolidated under a single brand name, EmVenio Clinical Research, effective August 25, 2025, uniting their complementary service lines under one entity within Professional Case Management. The rebranded company also launched Patient Navigator, a personalized support service designed to reduce logistical and financial barriers to clinical trial participation, particularly in rare diseases and pediatrics. EmVenio Clinical Research now operates in over 80 countries with approximately 5,000 professionals, claiming the ability to recruit more than 75% of patients from minority populations and retain over 92% of trial participants.PR NewswirePCM Trials, EmVenio Research und Clinical Trial Service firmieren um in EmVenio Clinical ResearchPCM Trials, EmVenio Research, and Clinical Trial Service have consolidated under a unified brand, EmVenio Clinical Research, uniting their complementary capabilities in decentralized clinical trials under a single operating name. The combined entity now operates in over 80 countries with approximately 5,000 professionals, leveraging mobile teams and community-based research sites to improve patient access and retention in clinical studies. EmVenio is also launching Patient Navigator, a personalized support service designed to reduce logistical and financial barriers to trial participation, particularly in rare diseases and pediatrics.PR NewswirePCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical ResearchEmVenio Clinical Research, a subsidiary of Professional Case Management, has consolidated three entities—PCM Trials, EmVenio Research, and Clinical Trial Service—under a unified brand to offer sponsors and contract research organizations greater flexibility and global reach. The company now operates in over 80 countries with approximately 5,000 professionals and has launched Patient Navigator™ to reduce logistical and financial barriers to clinical trial participation. PCM Trials, founded in 2008 and known for decentralized clinical trials, acquired Clinical Trial Service and EmVenio Research in 2024 to form this alliance.PcmtrialsPCM Trials Acquires Netherlands-Based Clinical Trial Service B.V.PCM Trials, a Denver-based provider of mobile research nurses, has acquired Clinical Trial Service (CTS), a Netherlands-based clinical research company with over 30 years of experience in decentralized clinical trials. The acquisition expands PCM Trials' global footprint to over 80 countries and eliminates an administrative layer to streamline operations for sponsors and CROs. Both entities will continue to operate under their respective brands while integrating their teams and logistics networks.PR NewswirePCM Trials Acquires Netherlands-Based Clinical Trial Service B.V., Becoming the Most Experienced Independent Provider of Mobile Visit Services with The Largest Geographic Coverage Area in Support of DPCM Trials, a Denver-based provider of mobile research nurses for decentralized clinical trials, announced the acquisition of Clinical Trial Service (CTS), a Netherlands-based private clinical research company. This acquisition expands PCM Trials' global footprint and combines their networks to offer services in over 80 countries with nearly 50 years of combined experience. The move aims to simplify contracting processes and improve operational efficiency for sponsors and CROs conducting global trials.